Dr. Michael Perkuhn

Enterprise digital business leadership role with global P&L-relevant accountability. Scope and Accountability -Global ownership of digital strategy, business models, and execution across 4 business units -Revenue ambition: double-digit €m digital revenue by 2030 Selected Impact -Defined and launched a global digital platform strategy spanning ordering, wound assessment, documentation -Scaled a global digital organisation -Led M&A scouting, due diligence, and valuation of company targets

Founder-led General Management role with full entrepreneurial P&L responsibility. -Full accountability for strategy, funding, commercial development, and delivery -Built and led a digital health & AI company integrating AI into clinical workflows Selected Achievements -Built the company without external investor capital -Secured customer-funded revenue prior to exit

Scope • Full P&L ownership (~double-digit m€ budget) • Leadership of 60 FTEs across Germany, Israel, India • Member of senior management team • Ownership of go-to-market, pricing, partnerships, and enterprise customers Impact • Built IntelliSpace AI from concept to independent global business unit • Scaled to ~double-digit m€ ARR with enterprise customers across multiple regions • Established international strategic partnerships • Product awarded “Best New Radiology Software” (AuntMinnie Europe, 2020)

• P&L ownership (~single- digit €m p.a.) • Leadership of 20 FTEs (Germany, India) • Adoption by 100+ university hospitals worldwide • Market leadership in China

MD Resident (Radiology) | Former Head of AI & Imaging Labs • Deep understanding of clinical workflows, regulation, and patient safety • Clinical AI research, validation, and workflow integration • Foundation for executive credibility with clinicians, regulators, and customers

• Evidenzgenerierung für klinische SW Applikationen in der Radiologie • Erfolgreiche Entwicklung von Innovationen in Datenkuration, Datenannotation und Training neuer Deep-Learning-Netzwerke • Auswertung und Analyse der klinischen Ergebnisse